CEL-SCI CORPORATION Stock-Based Compensation
CEL-SCI CORPORATION (CVM) reported Stock-Based Compensation of $1.35 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- CEL-SCI CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $454.09K, a 518.31% increase year-over-year.
- CEL-SCI CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $451.38K, a 34.17% decline year-over-year.
- CEL-SCI CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $443.27K, a 37.69% decline year-over-year.
- CEL-SCI CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $440.51K, a 39.29% decline year-over-year.
- CEL-SCI CORPORATION share-based payment arrangement, noncash expense for fiscal 2025 was $1.91M, a 55.25% decline from fiscal 2024.
- CEL-SCI CORPORATION share-based payment arrangement, noncash expense for fiscal 2024 was $4.27M, a 32.07% decline from fiscal 2023.
- CEL-SCI CORPORATION share-based payment arrangement, noncash expense for fiscal 2023 was $6.29M, a 44.81% decline from fiscal 2022.
- CEL-SCI CORPORATION share-based payment arrangement, noncash expense for fiscal 2022 was $11.39M, a 16.77% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 1 month | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $454.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | $905.48K derived: sum of 2 quarters · filed 2026-08-14 | $1.35M 10-Q · filed 2026-08-14 | $1.79M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $451.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $894.66K 10-Q · filed 2026-05-15 | $1.34M derived: sum of 3 quarters · filed 2026-05-15 | $1.41M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $443.27K 10-Q · filed 2026-02-17 | $883.78K derived: sum of 2 quarters · filed 2026-02-17 | $957.22K derived: sum of 3 quarters · filed 2026-08-14 | $1.64M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-09-30 | $440.51K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | $513.95K derived: sum of 2 quarters · filed 2026-08-14 | $1.20M derived: sum of 3 quarters · filed 2026-08-14 | $1.91M 10-K · filed 2025-12-29 | |
| 2025-06-30 | $73.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | $759.11K derived: sum of 2 quarters · filed 2026-08-14 | $1.47M 10-Q · filed 2026-08-14 | $2.20M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $685.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $1.40M 10-Q · filed 2026-05-15 | $2.12M derived: sum of 3 quarters · filed 2026-05-15 | $2.85M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $711.38K 10-Q · filed 2026-02-17 | $1.44M derived: sum of 2 quarters · filed 2026-02-17 | $2.17M derived: sum of 3 quarters · filed 2026-02-17 | $3.60M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-09-30 | $725.61K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | $1.45M derived: sum of 2 quarters · filed 2025-12-29 | $2.89M derived: sum of 3 quarters · filed 2025-12-29 | $4.27M 10-K · filed 2025-12-29 | |
| 2024-06-30 | $728.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-14 | $2.16M derived: sum of 2 quarters · filed 2025-08-14 | $3.54M 10-Q · filed 2025-08-14 | $4.85M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-04-19 | $260.00K 10-Q · filed 2025-05-14 | ||||
| 2024-03-31 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $2.82M 10-Q · filed 2025-05-14 | $4.13M derived: sum of 3 quarters · filed 2025-05-14 | $5.67M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $1.38M 10-Q · filed 2025-02-14 | $2.69M derived: sum of 2 quarters · filed 2025-02-14 | $4.23M derived: sum of 3 quarters · filed 2025-02-14 | $5.98M derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-09-30 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-13 | $2.85M derived: sum of 2 quarters · filed 2025-01-13 | $4.59M derived: sum of 3 quarters · filed 2025-01-13 | $6.29M 10-K · filed 2025-01-13 | |
| 2023-06-30 | $1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | $3.28M derived: sum of 2 quarters · filed 2024-08-14 | $4.98M 10-Q · filed 2024-08-14 | $7.26M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-15 | $3.44M 10-Q · filed 2024-05-15 | $5.72M derived: sum of 3 quarters · filed 2024-05-15 | $8.17M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $1.69M 10-Q · filed 2024-02-14 | $3.98M derived: sum of 2 quarters · filed 2024-02-14 | $6.43M derived: sum of 3 quarters · filed 2024-02-14 | $9.82M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-21 | $4.73M derived: sum of 2 quarters · filed 2023-12-21 | $8.13M derived: sum of 3 quarters · filed 2023-12-21 | $11.39M 10-K · filed 2023-12-21 | |
| 2022-06-30 | $2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-10 | $5.84M derived: sum of 2 quarters · filed 2023-08-10 | $9.10M 10-Q · filed 2023-08-10 | $12.70M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $6.66M 10-Q · filed 2023-05-12 | $10.25M derived: sum of 3 quarters · filed 2023-05-12 | $13.76M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $3.26M 10-Q · filed 2023-02-14 | $6.86M derived: sum of 2 quarters · filed 2023-02-14 | $10.37M derived: sum of 3 quarters · filed 2023-02-14 | $13.65M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-09-30 | $3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-27 | $7.11M derived: sum of 2 quarters · filed 2022-12-27 | $10.39M derived: sum of 3 quarters · filed 2022-12-27 | $13.69M 10-K · filed 2022-12-27 | |
| 2021-06-30 | $3.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12 | $6.79M derived: sum of 2 quarters · filed 2022-08-12 | $10.09M 10-Q · filed 2022-08-12 | $13.51M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $6.58M 10-Q · filed 2022-05-13 | $10.00M derived: sum of 3 quarters · filed 2022-05-13 | $13.11M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $3.30M 10-Q · filed 2022-02-11 | $6.72M derived: sum of 2 quarters · filed 2022-02-11 | $9.83M derived: sum of 3 quarters · filed 2022-02-11 | $11.61M derived: sum of 4 quarters · filed 2022-02-11 | |
| 2020-09-30 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-21 | $6.53M derived: sum of 2 quarters · filed 2021-12-21 | $8.31M derived: sum of 3 quarters · filed 2021-12-21 | $10.11M 10-K · filed 2021-12-21 | |
| 2020-06-30 | $3.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $4.89M derived: sum of 2 quarters · filed 2021-08-13 | $6.69M 10-Q · filed 2021-08-13 | $8.49M derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-17 | $3.58M 10-Q · filed 2021-05-17 | $5.38M derived: sum of 3 quarters · filed 2021-05-17 | $6.90M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $1.80M 10-Q · filed 2021-02-12 | $3.60M derived: sum of 2 quarters · filed 2021-02-12 | $5.12M derived: sum of 3 quarters · filed 2021-02-12 | $5.65M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-09-30 | $1.80M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-12-29 | $3.32M derived: sum of 2 quarters · filed 2020-12-31 | $3.85M derived: sum of 3 quarters · filed 2020-12-31 | $4.43M 10-K · filed 2020-12-29 | |
| 2019-06-30 | $1.52M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2020-12-31 | $2.05M derived: sum of 2 quarters · filed 2020-12-31 | $2.63M 10-Q/A · filed 2020-12-31 | $3.18M derived: sum of 4 quarters · filed 2020-12-31 | |
| 2019-03-31 | $530.83K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2020-12-30 | $1.10M 10-Q/A · filed 2020-12-30 | $1.65M derived: sum of 3 quarters · filed 2020-12-30 | $2.12M derived: sum of 4 quarters · filed 2020-12-30 | |
| 2018-12-31 | $573.66K 10-Q/A · filed 2020-12-30 | $1.12M derived: sum of 2 quarters · filed 2020-12-30 | $1.59M derived: sum of 3 quarters · filed 2020-12-30 | $1.87M derived: sum of 4 quarters · filed 2020-12-30 | |
| 2018-09-30 | $549.87K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | $1.02M derived: sum of 2 quarters · filed 2019-12-23 | $1.30M derived: sum of 3 quarters · filed 2019-12-23 | $2.74M 10-K/A · filed 2019-12-23 | |
| 2018-06-30 | $465.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $745.30K derived: sum of 2 quarters · filed 2019-08-14 | $2.19M 10-Q · filed 2019-08-14 | $2.57M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $279.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | $1.73M 10-Q · filed 2019-05-14 | $2.11M derived: sum of 3 quarters · filed 2019-05-14 | $2.43M derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | $1.45M 10-Q · filed 2019-02-14 | $1.83M derived: sum of 2 quarters · filed 2019-02-14 | $2.15M derived: sum of 3 quarters · filed 2019-02-14 | $2.52M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2017-09-30 | $377.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-19 | $702.75K derived: sum of 2 quarters · filed 2018-12-19 | $1.07M derived: sum of 3 quarters · filed 2018-12-19 | $1.38M 10-K · filed 2018-12-19 | |
| 2017-06-30 | $325.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $690.55K derived: sum of 2 quarters · filed 2018-08-14 | $1.00M 10-Q · filed 2018-08-14 | $1.85M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $365.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | $677.75K 10-Q · filed 2018-05-15 | $1.53M derived: sum of 3 quarters · filed 2018-05-15 | $1.95M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $312.38K 10-Q · filed 2018-02-12 | $1.16M derived: sum of 2 quarters · filed 2018-02-12 | $1.58M derived: sum of 3 quarters · filed 2018-02-12 | $2.00M derived: sum of 4 quarters · filed 2018-02-12 | |
| 2016-09-30 | $849.77K derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-12-29 | $1.27M derived: sum of 2 quarters · filed 2017-12-29 | $1.69M derived: sum of 3 quarters · filed 2017-12-29 | $2.11M 10-K · filed 2017-12-29 | |
| 2016-06-30 | $418.56K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-12-11 | $835.75K derived: sum of 2 quarters · filed 2017-12-11 | $1.26M 10-Q/A · filed 2017-12-11 | $1.80M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2016-03-31 | $417.19K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-12-11 | $845.10K 10-Q/A · filed 2017-12-11 | $1.38M derived: sum of 3 quarters · filed 2017-12-11 | $2.00M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2015-12-31 | $427.91K 10-Q/A · filed 2017-12-11 | $962.74K derived: sum of 2 quarters · filed 2017-12-11 | $1.58M derived: sum of 3 quarters · filed 2017-12-11 | $2.47M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2015-09-30 | $534.83K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $1.15M derived: sum of 2 quarters · filed 2017-12-11 | $2.05M derived: sum of 3 quarters · filed 2017-12-11 | $5.11M 10-K/A · filed 2017-12-11 | |
| 2015-06-30 | $619.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $1.51M derived: sum of 2 quarters · filed 2016-08-09 | $4.57M 10-Q · filed 2016-08-09 | $7.04M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2015-03-31 | $892.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | $3.95M 10-Q · filed 2016-05-10 | $6.42M derived: sum of 3 quarters · filed 2017-12-11 | $6.88M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2014-12-31 | $3.06M 10-Q · filed 2016-02-09 | $5.53M derived: sum of 2 quarters · filed 2017-12-11 | $5.99M derived: sum of 3 quarters · filed 2017-12-11 | $6.51M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2014-09-30 | $2.47M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $2.93M derived: sum of 2 quarters · filed 2017-12-11 | $3.45M derived: sum of 3 quarters · filed 2017-12-11 | $3.96M 10-K/A · filed 2017-12-11 | |
| 2014-06-30 | $462.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-07 | $982.86K derived: sum of 2 quarters · filed 2015-08-07 | $1.49M 10-Q · filed 2015-08-07 | $2.04M derived: sum of 4 quarters · filed 2015-12-11 | |
| 2014-03-31 | $520.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $1.03M 10-Q · filed 2015-05-08 | $1.58M derived: sum of 3 quarters · filed 2015-12-11 | $2.14M derived: sum of 4 quarters · filed 2015-12-11 | |
| 2013-12-31 | $510.28K 10-Q · filed 2015-02-06 | $1.06M derived: sum of 2 quarters · filed 2015-12-11 | $1.62M derived: sum of 3 quarters · filed 2015-12-11 | ||
| 2013-09-30 | $549.19K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $1.11M derived: sum of 2 quarters · filed 2015-12-11 | $2.64M 10-K · filed 2015-12-11 | ||
| 2013-06-30 | $564.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-08 | $2.09M 10-Q · filed 2014-08-08 | |||
| 2013-03-31 | $1.52M 10-Q · filed 2014-05-12 | ||||
| 2012-09-30 | $2.23M 10-K · filed 2014-12-23 | ||||
| 2009-09-30 | $685.86K 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |